Citigroup Upgrades American Healthcare REIT to Buy, Maintains Price Target to $55
Benzinga Newsdesk 4 months ago
NewsUpgradesAnalyst RatingsPrice Target
Citigroup analyst Nick Joseph upgrades American Healthcare REIT (NYSE:AHR) from Neutral to Buy and maintains the price target from $55 to $55.
Citigroup analyst Nick Joseph upgrades American Healthcare REIT (NYSE:AHR) from Neutral to Buy and maintains the price target from $55 to $55.